Cuesta Licensing Partners with Black-Owned Brand Mah Melanin to Bring Culturally Inspired Products to the Licensing Market
Boutique Licensing Agency Joins Forces with Trailblazing Lifestyle Brand to Expand Representation Across New Product Categories
Water Tower Research Publishes Initiation of Coverage Report on Herbalife Ltd., “Adapting to the Times; Well Positioned for Long-Term Growth”December 4, 2024, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Herbalife Ltd. (NYSE:
HLF) titled, “Adapting to the Times; Well Positioned for Long-Term Growth”. The report can be accessed here.
Kaplan Fox & Kilsheimer LLP is Investigating Applied Therapeutics, Inc. (APLT) for Potential Securities Law ViolationsNEW YORK - (NewMediaWire) - December 04, 2024 - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ:
APLT).
New Book Challenges Media and Government Narratives Around Canada's Freedom Convoy
December 4, 2024 – TheNewswire - WINNIPEG – Amid heated debates about government accountability and civil liberties, the Frontier Centre for Public Policy has released a powerful new book, Unjustified: The Freedom Convoy, The Emergencies Act, And The Inquiry That Got It Wrong by Ray McGinnis. This timely and provocative work calls on Canadians to rethink their assumptions about the 2022 Freedom Convoy protests and the government’s unprecedented invocation of the Emergencies Act.
Class Action Lawsuit Reminder (PACS): Kessler Topaz Meltzer & Check, LLP Reminds PACS Group, Inc. Investors - A Securities Fraud Class Action Lawsuit Has Been FiledRADNOR, Pa. - (NewMediaWire) - December 03, 2024 - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against PACS Group, Inc. (“PACS”) (NYSE:
PACS). The lawsuit is brought on behalf of investors who purchased or otherwise acquired PACS: 1) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with PACS’ April 11, 2024 initial public offering (the “IPO”); and/or 2) securities between April 11, 2024 and November 5, 2024 inclusive (the “Class Period”). The lead plaintiff deadline is January 13, 2025.
Important December 16, 2024 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Acadia Healthcare Company, Inc. Investors of Securities Fraud Class Action LawsuitRADNOR, Pa. - (NewMediaWire) - December 03, 2024 - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Acadia Healthcare Company, Inc. (“Acadia Healthcare”) (NASDAQ:
ACHC) on behalf of investors who purchased or otherwise acquired Acadia Healthcare securities between February 28, 2020 and October 18, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 16, 2024.
Class Action Lawsuit Reminder (CELH): Kessler Topaz Meltzer & Check, LLP Reminds Celsius Holdings, Inc. Investors - A Securities Fraud Class Action Lawsuit Has Been FiledRADNOR, Pa. - (NewMediaWire) - December 03, 2024 - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Celsius Holdings, Inc. (“Celsius”) (NASDAQ:
CELH) on behalf of those who purchased or otherwise acquired Celsius common stock between February 29, 2024, and September 4, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 21, 2025.
EW DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Edwards Lifesciences Corporation Securities Fraud Class Action LawsuitRADNOR, Pa. - (NewMediaWire) - December 03, 2024 - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards”) (NYSE:
EW) on behalf of investors who purchased or otherwise acquired Edwards securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”) The lead plaintiff deadline is December 13, 2024.
